Robin L Reynolds, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 560 W Mitchell St Ste 250, Petoskey, MI 49770 Phone: 231-487-3277 Fax: 231-487-6167 |
Dr. Kathleen Marie Kelly, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 2325 Summit Park Dr, Suite B, Petoskey, MI 49770 Phone: 231-347-1800 Fax: 231-347-1864 |
Dr. Michael Koskus, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 820 Arlington Ave, Petoskey, MI 49770 Phone: 231-348-3666 Fax: 231-348-6456 |
Amy Cullen, M.S. CCCA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2325 Summit Park Dr, Suite B, Petoskey, MI 49770 Phone: 231-347-1800 Fax: 231-347-1864 |
Sarah Jeanne Pilkington, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 560 W Mitchell St Ste 250, Petoskey, MI 49770 Phone: 231-487-3277 |
Lindsay Reckinger, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1114 Charlevoix Ave, Petoskey, MI 49770 Phone: 231-489-8151 Fax: 231-668-7794 |
Molly Ann Clark, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 560 W Mitchell St Ste 250, Petoskey, MI 49770 Phone: 123-487-3277 Fax: 231-487-6167 |
Mr. John M Goy, M.A.,CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 Madison St, Petoskey, MI 49770 Phone: 231-348-3666 Fax: 231-348-6456 |
Dr. Adam Jens Wong, AU.D. CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 2206 Mitchell Park Dr Ste 13b, Petoskey, MI 49770 Phone: 517-862-3043 |
News Archive
New Magnetic Resonance Technologies and Applications Open New Frontiers for Biological, Chemical and Materials Research and Routine Analysis in Pharmaceutical and Chemical Industries.
Athersys, Inc. today announced its financial results for the quarter ended June 30, 2010.
The Centre for Drug Research and Development announced today the signing of affiliation agreements with both the University of Calgary and University Technologies International.
The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction.
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
› Verified 8 days ago